| Decoupling of sleep-dependent cortical and hippocampal interactions in a neurodevelopmental model of schizophrenia KG Phillips, U Bartsch, AP McCarthy, DM Edgar, MD Tricklebank, ... Neuron 76 (3), 526-533, 2012 | 147 | 2012 |
| Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia KG Phillips, MC Cotel, AP McCarthy, DM Edgar, M Tricklebank, MJ O’neill, ... Neuropharmacology 62 (3), 1359-1370, 2012 | 107 | 2012 |
| A selective nociceptin receptor antagonist to treat depression: evidence from preclinical and clinical studies A Post, TS Smart, J Krikke-Workel, GR Dawson, CJ Harmer, M Browning, ... Neuropsychopharmacology 41 (7), 1803-1812, 2016 | 106 | 2016 |
| REM sleep’s unique associations with corticosterone regulation, apoptotic pathways, and behavior in chronic stress in mice M Nollet, H Hicks, AP McCarthy, H Wu, CS Möller-Levet, EE Laing, ... Proceedings of the National Academy of Sciences 116 (7), 2733-2742, 2019 | 76 | 2019 |
| In vitro characterisation of the novel positive allosteric modulators of the mGlu5 receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant … G Gilmour, LM Broad, KA Wafford, T Britton, EM Colvin, A Fivush, ... Neuropharmacology 64, 224-239, 2013 | 65 | 2013 |
| REM sleep homeostasis in the absence of REM sleep: Effects of antidepressants A McCarthy, K Wafford, E Shanks, M Ligocki, DM Edgar, DJ Dijk Neuropharmacology 108, 415-425, 2016 | 49 | 2016 |
| The Escherichia coli TatABC system and a Bacillus subtilis TatAC-type system recognise three distinct targeting determinants in twin-arginine signal peptides S Mendel, A McCarthy, JP Barnett, RT Eijlander, A Nenninger, OP Kuipers, ... Journal of molecular biology 375 (3), 661-672, 2008 | 35 | 2008 |
| Electrophysiological assessment methodology of sensory processing dysfunction in schizophrenia and dementia of the Alzheimer type P Danjou, G Viardot, D Maurice, P Garcés, EJ Wams, KG Phillips, ... Neuroscience & Biobehavioral Reviews 97, 70-84, 2019 | 30 | 2019 |
| The M1/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brain C Montani, C Canella, AJ Schwarz, J Li, G Gilmour, A Galbusera, ... Neuropsychopharmacology 46 (6), 1194-1206, 2021 | 29 | 2021 |
| Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration CM Holton, N Hanley, E Shanks, P Oxley, A McCarthy, BJ Eastwood, ... Alzheimer's Research & Therapy 12, 1-15, 2020 | 29 | 2020 |
| Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking … CM Wood, KA Wafford, AP McCarthy, N Hewes, E Shanks, D Lodge, ... Neuropharmacology 140, 246-259, 2018 | 16 | 2018 |
| Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC-611), a selective antagonist of TARP-γ8-associated AMPA receptors JM Witkin, J Li, G Gilmour, SN Mitchell, G Carter, SD Gleason, WF Seidel, ... Neuropharmacology 126, 257-270, 2017 | 15 | 2017 |
| Distinct pro-vigilant profile induced in rats by the mGluR5 potentiator LSN2814617 S Loomis, A McCarthy, C Baxter, DO Kellett, DM Edgar, M Tricklebank, ... Psychopharmacology 232 (21-22), 3977-3989, 2015 | 15 | 2015 |
| Modelling maintenance of wakefulness in rats: comparing potential non‐invasive sleep‐restriction methods and their effects on sleep and attentional performance A Mccarthy, S Loomis, B Eastwood, KA Wafford, R Winsky‐Sommerer, ... Journal of sleep research 26 (2), 179-187, 2017 | 12 | 2017 |
| Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations C Brittain, A McCarthy, MC Irizarry, D McDermott, K Biglan, GU Höglinger, ... Parkinsonism & related disorders 60, 138-145, 2019 | 11 | 2019 |
| Pharmacological modulation of sleep homeostasis in rat: novel effects of an mGluR2/3 antagonist N Hanley, J Paulissen, BJ Eastwood, G Gilmour, S Loomis, KA Wafford, ... Sleep 42 (9), zsz123, 2019 | 7 | 2019 |
| The dopamine D1 receptor positive allosteric modulator mevidalen (LY3154207) enhances wakefulness in the humanized D1 mouse and in sleep-deprived healthy male volunteers AP McCarthy, KA Svensson, E Shanks, C Brittain, BJ Eastwood, ... Journal of Pharmacology and Experimental Therapeutics 380 (3), 143-152, 2022 | 6 | 2022 |
| Evaluating the use of digital biomarkers to test treatment effects on cognition and movement in patients with Lewy body dementia J Wang, C Battioui, A McCarthy, X Dang, H Zhang, A Man, J Zou, J Kyle, ... Journal of Parkinson's Disease 12 (6), 1991-2004, 2022 | 5 | 2022 |
| Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study S Loiodice, WH Drinkenburg, A Ahnaou, A McCarthy, G Viardot, E Cayre, ... Translational Psychiatry 11 (1), 253, 2021 | 4 | 2021 |
| Population Pharmacokinetic/Pharmacodynamic Modelling of Auditory‐Evoked Event‐Related Potentials with Lorazepam A Lombard, C Brittain, G Wishart, S Lowe, A McCarthy, W Landschulz, ... Basic & Clinical Pharmacology & Toxicology 122 (2), 245-252, 2018 | 4 | 2018 |
